COVID Target Stable Cell Lines
COVID Target Stable Cell Lines
Spike protein of SARS-CoV-2 (previously named 2019-nCoV) is composed of a S1 domain and S2 domain. The S1 domain contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. Cell entry of coronavirus depends on the spike (S) protein binding to a cellular receptor and priming by a cellular protease. Studies demonstrate that angiotensin-converting enzyme 2 (ACE2) serves as the cell surface receptor to bind S protein in SARS-CoV-2 and facilitates entry of these coronaviruses into the cell.
GenScript has developed single clone-derived stable cell lines with high expression of Spike protein of SARS-CoV-2 or human ACE2 (hACE2) to assist and accelerate COVID-19 research.
Validated Expression​​

Validated Expression

Single Clone

Single Clone

High Signal-to-Background Ration

High Signal-to-Background Ratio

>15 Passages Validated

>15 Passages Validated

Application

Resources

Stable Cell Lines Products

Stable Cell Line Products

Simplify Your Assay

Free Download

/webinars/speed-up-your-drug-discovery-with-ready-to-use-stable-cell-lines.html

Free Download

Related Products

REQUEST A QUOTE